Pleurisy occurring as a manifestation of post-cardiac injury syndrome represents a specific inflammatory clinical scenario. Identifying the underlying syndrome as the driver is essential to guiding appropriate management.
This protocol addresses pleuritis arising in the context of post-cardiac injury syndrome — an inflammatory condition following cardiac injury. The syndromic context distinguishes this presentation and directly shapes the therapeutic approach.
NSAIDs are first-line therapy for patients with post–cardiac injury syndrome; corticosteroids are reserved for those who are intolerant of or experience no response to NSAIDs.
View source ↗